中国临床药学杂志

参考文献

1 Westphal JF,Blickle JF,Brogard JM. Management of biliary tractinfections:potential role of the quinolones.JAntimicrob Chemot-her,1991,2 4( 4 ) :486

2 Maluenda F,Csendes A,Burdiles P,etal.Bacteriological study ofcholedochal bile in patients with com mon bile duct stone,with orwithout acute suppurative cholangitis. Hepatogastroenterology,1989,3 6( 3 ) :13 2

3 Mandell LA.Role of quinolones in surgical prophylaxis. Eur JClinMicrobiol Infect Dis,1991,10 ( 4 ) :3 68

4吴永乐 ,张永信 .新氟喹诺酮抗菌药 .国外医药·抗生素分册 ,1996,17( 1) :5 1

5郭惠元 .吡酮酸类抗感染药物的回顾与展望 .国外医药·抗生素分册 ,1996,17( 6) :42 9

6王洪权 ,郭惠元 .喹诺酮研究新进展 .国外医药·抗生素分册 ,1996,17( 5 ) :3 67

7王金生 (译 ) .新氟喹诺酮类药物的抗微生物疗法 .国外医药·抗生素分册 ,1993 ,14 ( 6) :447

8Daris R,Bryson HM.Levofloxacin,a review of its antibacterialactivity,pharmacokinetics and therapeutic efficacy. Drugs,1994,47( 4 ) :677

9田治明 ,郭惠元 .新喹诺酮的药代动力学性质 .国外医药·抗生素分册 ,1995 ;16( 1) :60

10 Hayton WL,Rlahov V,Bacrachera N,et al.Pharmacokineticsand biliary concentrations of fleroxacin in cholecystectomizedpatients.Antimicrob Agents Chemother,1990 ,3 4 :2 3 75

11Dan M,Verbin N,Gorea A,etal.Concentration of ciprofloxacinin human liver,gallbladder,and bile following oraladministration.Rev Infect Dis,1988,10 ( Suppl1) :S12 5

12 Tanimura H,Ishimoto K,Yukawa H,et al. Excretion into bileand gallbladder tissue level of a new quinolone,sparfloxacin andits clinical efficacy on surgical infections. Chemotherapy,199139:62 0

13 Kazm ierczak A,Pechinot A,Duez JM,et al. Biliary tractexcretion of ofloxacin in m an. Drugs,1987,2 4:3 9

14 Tanimura H,Onishi H,Okamura M,etal. Chemotherapy of bi-liary tract infections ( ) ,excretion into bile andgallbladder tissve levels of levofloxacin and its clinical effect inbiliary tract infections. Jpn JAntibiot,1992 ,45 :5 5 7

15 Kujath P. Antibiotic prophylaxis in biliary tract surgeryciprofloxacin versus ceftriaxone.Am JMed,1989,87( 5 A) :2 5 5

16Chrysanthopoul CJ,Skoutelis AT,Starakis JC,et al.Use ofciprofloxacin in biliary sepsis. Infection,1988,16:2 49

17Chacon JP,Criscuolo PD,Kobata CM,et al. Pefloxacin vsampicillin plus gentamicin for the treatment of biliary tractinfections.Rev Infect Dis,1989,11( Suppl5 ) :S12 99

18Chrysanthopoulus CJ,Skoutelis AT,Starakis JC,et al. U se ofintravenous ciprofloxacin in respiratory tract infections andbiliary sepsis. Am JMed,1987,82 ( Suppl 4A) :3 5 7

19Fried M,Peskova M. A randomized trial of pefloxacin plusclindam ycin and cefoxitin in hepatobiliary and pancreaticsurgery.Hepatogastroenterology,1996,43 ( 7) :3 0 6

2 0 Sung JJ,Lyou DJ,Suen R,et al. Intravenous ciprofloxacin astreatment for patients with acute suppurative cholangitis:arandomized. Controlled Clinical Trial. J Antimicrob,Chemother,1995 ,3 5 ( 6) :85 5

2 1Mc Ardle CS,Morran CG,Pettit L,et al. The value of oralantibiotic prophylaxis in biliary tract surgery. JHospital Infect,1991,19( Suppl C) :5 9

2 2 Kogler J,Hancke E,Marklein G,et al.Ciprofloxacin for singleshot prophylaxis during cholecystectom y.Infection,1989,17:174